Neuroprotective effect of pioglitazone in the 6-hydroxydopamine model of Parkinson’s disease

Authors :: Maria A.B.F. Vital
S. Zanata
T.B. Bassani
E.L.R. Moura
V. Cóppola-Segovia
M.M.F. Machado
Source :: European Neuropsychopharmacology. 26:S652
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Pharmacology
Hydroxydopamine
Parkinson's disease
business.industry
medicine.disease
Neuroprotection
Psychiatry and Mental health
Neurology
medicine
Pharmacology (medical)
Neurology (clinical)
business
Pioglitazone
Biological Psychiatry
medicine.drug

Full Text Access

Tools